| Ccl2 | C-C motif chemokine 2 |
| Cd38 | Cluster of differentiation 38 |
| c-Met | Tyrosine-protein kinase Met |
| Cxcl12 | C-X-C motif chemokine 12 |
| CVD | Cardiovascular disease |
| DICER | Endoribonuclease Dicer |
| DMEM | Dulbecco’s Modified Eagle Medium |
| DROSHA | Ribonuclease type III |
| ELISA | Enzyme-linked Immunosorbent assay |
| Extl3 | Exostosin-like 3 |
| FCS | Fetal calf serum |
| Flk-1 | Fetal liver kinase receptor 1 |
| Flt-1 | Fms-like tyrosine kinase 1 |
| HGFIdU | Hepatocyte growth factor5-Iodo-2ʹ-deoxyuridine |
| IH | Intermittent hypoxia |
| Il | Interleukin |
| MEMα | Minimum Essential Medium Alpha Modification |
| miR | MicroRNA |
| PAP | Pancreatitis associated protein |
| Reg | Regenerating gene |
| RpS15 | Ribosomal protein S15 |
| RT-PCR | Reverse transcriptase-polymerase chain reaction |
| SAS | Sleep apnea syndrome |
| SH | Sustained hypoxia |
| TGFβ1 | Transforming growth factor β1 |
| Tnfα | Tumor necrosis factor-α |
| TUNEL | TdT-mediated dUTP nick end labeling |
| Vegf-A | Vascular endothelial growth factor A |
| WST-8 | 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt |